Sort   by:  
 Page size 
UnknownLongitudinal change in regional brain volumes in prodromal Huntington disease.
Not available
S-EPMC3105627 | biostudies-literature
UnknownWHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease.
Not available
S-EPMC4350592 | biostudies-literature
UnknownUnawareness of motor phenoconversion in Huntington disease.
Not available
S-EPMC3795599 | biostudies-literature
UnknownMultivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease.
Not available
S-EPMC4640959 | biostudies-literature
UnknownA randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.
Not available
S-EPMC5224719 | biostudies-literature
UnknownRegional atrophy associated with cognitive and motor function in prodromal Huntington disease.
Not available
S-EPMC4412155 | biostudies-literature
UnknownMotor onset and diagnosis in Huntington disease using the diagnostic confidence level.
Not available
S-EPMC4666501 | biostudies-literature
UnknownCystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.
Not available
S-EPMC1430359 | biostudies-literature
UnknownDepressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease.
Not available
S-EPMC3806339 | biostudies-literature
UnknownDecreased Lin7b expression in layer 5 pyramidal neurons may contribute to impaired corticostriatal connectivity in huntington disease.
Not available
S-EPMC3376025 | biostudies-literature
Sort   by:  
 Page size